Radioembolization lung shunt estimation based on a 90 Y pretreatment procedure: A phantom study
- PMID: 30179259
- DOI: 10.1002/mp.13168
Radioembolization lung shunt estimation based on a 90 Y pretreatment procedure: A phantom study
Abstract
Purpose: Prior to 90 Y radioembolization, a pretreatment procedure is performed, in which 99m Tc-macroaggerated albumin (99m Tc-MAA) is administered to estimate the amount of activity shunting to the lungs. A high lung shunt fraction (LSF) may impose lower prescribed treatment activity or even impede treatment. Accurate LSF measurement is therefore important, but is hampered by the use of MAA particles, which differ from 90 Y microspheres. Ideally, 90 Y microspheres would also be used for the pretreatment procedure, but this would require the activity to be lower than an estimated safety threshold of about 100 MBq to avoid unintended radiation damage. However, 90 Y is very challenging to image, especially at low activities (<100 MBq). The purpose of this study was to evaluate the performance of three nuclear imaging techniques in estimating the LSF in a low activity 90 Y pretreatment scan, using an anthropomorphic phantom: (a) positron emission tomography/computed tomography (PET/CT), (b) Bremsstrahlung single photon emission tomography/computed tomography (SPECT/CT), and (c) planar imaging.
Methods: The lungs and liver of an anthropomorphic phantom were filled with 90 Y chloride to acquire an LSF of 15%. Several PET/CT (Siemens Biograph mCT), Bremsstrahlung SPECT/CT (Siemens Symbia T16) and planar images (Siemens Symbia T16) were acquired at a range of 90 Y activities (1586 MBq down to 25 MBq). PET images were reconstructed using a clinical protocol (attenuation correction, TOF, scatter and random correction, OP-OSEM), SPECT images were reconstructed using both a clinical protocol (attenuation correction, OSEM) and a Monte Carlo (MC)-based reconstruction method (MC-based detector, scatter, and attenuation modeling, OSEM), for planar images the geometric mean was calculated. In addition, in all cases except clinical SPECT, background correction was included. The LSF was calculated by assessing the reconstructed activity in the lungs and in the liver, as delineated on the CT images. In addition to the 15% LSF, an extra "cold" region was included to simulate an LSF of 0%.
Results: PET reconstructions accurately estimated the LSF (absolute difference <2 percent point (pp)) when total activity was over 200 MBq, but greatly overestimated the LSF (up to 25pp) when activity decreased. Bremsstrahlung SPECT clinical reconstructions overestimated the LSF (up to 13pp) when activity was both high and low. Similarly, planar images overestimated the LSF (up to 23pp). MC-based SPECT reconstructions accurately estimated the LSF with an absolute difference of less than 1.3pp for activities as low as 70 MBq.
Conclusions: Bremsstrahlung SPECT/CT can accurately estimate the LSF for a 90 Y pretreatment procedure using a theoretically safe 90 Y activity as low as 70 MBq, when reconstructed with an MC-based model.
Keywords: PET; SPECT; lung shunt fraction; radioembolization; yttrium-90 pretreatment procedure.
© 2018 The Authors. Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.
Similar articles
-
Feasibility of imaging 90 Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning.Med Phys. 2020 Mar;47(3):1105-1114. doi: 10.1002/mp.13974. Epub 2020 Jan 20. Med Phys. 2020. PMID: 31855282 Free PMC article.
-
Hepatopulmonary Shunt Ratio Verification Model for Transarterial Radioembolization.Curr Radiopharm. 2024;17(3):276-284. doi: 10.2174/0118744710284130240108053733. Curr Radiopharm. 2024. PMID: 38288829
-
PET/CT and SPECT/CT imaging of 90Y hepatic radioembolization at therapeutic and diagnostic activity levels: Anthropomorphic phantom study.PLoS One. 2024 Feb 29;19(2):e0271711. doi: 10.1371/journal.pone.0271711. eCollection 2024. PLoS One. 2024. PMID: 38421965 Free PMC article.
-
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):559-75. doi: 10.1007/s00259-015-3157-8. Epub 2015 Sep 4. Eur J Nucl Med Mol Imaging. 2016. PMID: 26338177 Free PMC article. Review.
-
Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres.World J Nucl Med. 2015 May-Aug;14(2):75-80. doi: 10.4103/1450-1147.157120. World J Nucl Med. 2015. PMID: 26097416 Free PMC article. Review.
Cited by
-
Feasibility of imaging 90 Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning.Med Phys. 2020 Mar;47(3):1105-1114. doi: 10.1002/mp.13974. Epub 2020 Jan 20. Med Phys. 2020. PMID: 31855282 Free PMC article.
-
Comparison of the Biograph Vision and Biograph mCT for quantitative 90Y PET/CT imaging for radioembolisation.EJNMMI Phys. 2020 Mar 4;7(1):14. doi: 10.1186/s40658-020-0283-6. EJNMMI Phys. 2020. PMID: 32130554 Free PMC article.
-
Hepatopulmonary Shunt Ratio Verification Model for Transarterial Radioembolization.Curr Radiopharm. 2024;17(3):276-284. doi: 10.2174/0118744710284130240108053733. Curr Radiopharm. 2024. PMID: 38288829
-
Using Deep Learning to Predict Treatment Response in Patients with Hepatocellular Carcinoma Treated with Y90 Radiation Segmentectomy.J Digit Imaging. 2023 Jun;36(3):1180-1188. doi: 10.1007/s10278-022-00762-0. Epub 2023 Jan 11. J Digit Imaging. 2023. PMID: 36629989 Free PMC article.
-
AAPM Medical Physics Practice Guideline 14.a: Yttrium-90 microsphere radioembolization.J Appl Clin Med Phys. 2024 Feb;25(2):e14157. doi: 10.1002/acm2.14157. Epub 2023 Oct 11. J Appl Clin Med Phys. 2024. PMID: 37820316 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous